Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) selectively induces apoptotic cell death in cancer cells but has no effect on normal cells, therefore, it has obtained interest as a promising agent for cancer therapy [1]. Here, TNF is linked to cancer.